PANTHERx® Rare Selected by UCB as the Exclusive Specialty Pharmacy for the Distribution of KYGEVVI™
PITTSBURGH – PANTHERx® Rare, the trusted leader and innovator in patient access and support services for personalized rare disease care, announced that it was selected by UCB as the exclusive specialty pharmacy for the distribution of KYGEVVI™ (doxecitine...
Read MorePANTHERx® Rare Selected by Rhythm Pharmaceuticals Inc. as the Exclusive U.S. Specialty Pharmacy for the Expanded Indication for IMCIVREE® (setmelanotide)
PITTSBURGH – PANTHERx® Rare Pharmacy, the trusted leader and innovator in patient access and support services for personalized rare disease care, announced that it was selected by Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), as the exclusive U.S. Pharmacy...
Read MoreAs Rare Disease Drug Approvals Accelerate, PANTHERx® Releases Research on Strengthening Care Coordination
Report released for Rare Disease Day shows that while these diseases are rare, the barriers that patients face are unfortunately all too common PITTSBURGH – As the world prepares to mark Rare Disease Day on February 28, the rare disease community faces...
Read MorePANTHERx® Rare Selected by Savara as the U.S. Exclusive Specialty Pharmacy for MOLBREEVI*
PITTSBURGH – PANTHERx® Rare Pharmacy, the trusted leader and innovator in patient access and support services for personalized rare disease care and Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases,...
Read MorePANTHERx® Rare Selected by Otsuka America Pharmaceutical, Inc. to Dispense VOYXACT® (sibeprenlimab-szsi) for the Treatment of Primary Immunoglobulin A Nephropathy
PITTSBURGH – PANTHERx® Rare Pharmacy, the trusted leader and innovator in patient access and support services for personalized rare disease care, announced that it was selected by Otsuka America Pharmaceutical, Inc. (OAPI) as the exclusive specialty pharmacy...
Read MorePANTHERx® Rare Selected by Chiesi for the Distribution of MYCAPSSA®
PITTSBURGH – PANTHERx® Rare has been chosen by Chiesi as the exclusive specialty pharmacy to distribute MYCAPSSA® (octreotide). The partnership aims to improve patient access and support for individuals living with acromegaly. MYCAPSSA® is an oral somatostatin...
Read More